2009
DOI: 10.1002/anie.200805900
|View full text |Cite
|
Sign up to set email alerts
|

Probing the Bioactive Conformation of an Archetypal Natural Product HDAC Inhibitor with Conformationally Homogeneous Triazole‐Modified Cyclic Tetrapeptides

Abstract: Keywords drug design; cyclic peptides; histone deacetylase; structure-activity relationship; triazole A fundamental strategy in rationally designing synthetic compounds to bind a protein of interest is to use a known ligand as a structural model to specify the precise conformational and pharmacophoric requirements for binding. Despite the remarkable success of this approach, a significant difficulty is that free ligands (in the absence of their cognate receptors) often adopt multiple conformations in solution … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
101
0
2

Year Published

2010
2010
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 144 publications
(104 citation statements)
references
References 65 publications
1
101
0
2
Order By: Relevance
“…[53] Apicidin is an inhibitor of histone deacetylase (HDAC) that exhibits potent cytotoxicity towards cancer cells. Several analogues of apicidin (e.g., see Scheme 2), containing either a 1,4-substituted or 1,5-substituted triazole to mimic a trans-amide or a cis-amide bond, respectively, were synthesised to gain some insight into the bioactive conformation of apicidin.…”
Section: Head-to-tail Cyclisationmentioning
confidence: 99%
“…[53] Apicidin is an inhibitor of histone deacetylase (HDAC) that exhibits potent cytotoxicity towards cancer cells. Several analogues of apicidin (e.g., see Scheme 2), containing either a 1,4-substituted or 1,5-substituted triazole to mimic a trans-amide or a cis-amide bond, respectively, were synthesised to gain some insight into the bioactive conformation of apicidin.…”
Section: Head-to-tail Cyclisationmentioning
confidence: 99%
“…First, we have described a protocol for the macrocyclic ring closure of chiral α-azido acids via regioselective and epimerization-free 1,5-disubstituted triazole formation. The macrocycle products were obtained in superior yields to those described in the literature (47). Second, we have reported the development of a unique method for the DKP synthesis using solid-supported N methylmorpholine in combination with microwave heating.…”
Section: Discussionmentioning
confidence: 88%
“…Though there are numerous reported examples of the use of regioselective 1,3-dipolar cycloadditions to furnish 1,4-triazole containing macrocycles (58), only a handful of these employed chiral α-azido acids as the substrates (48,59,60). The synthesis of 1,5-triazole containing macrocycles via 1,3-dipolar cycloadditions (61) is much less common, and in the very limited number of examples that use α-azido acid containing substrates, the yields of the isolated products are typically very low (47). A method where the formation of the macrocycle proceeded with good regioselectivity (1,5-triazole over 1,4-triazole) and moderate yields has been recently described, but there were no stereogenic centers adjacent to the azide present in the substrates (62,63).…”
Section: Boc-l-lys(z)-ohmentioning
confidence: 99%
See 1 more Smart Citation
“…Cyclization of peptides can lead to enhanced specificity, [5] in vivo proteolytic stability, [6] and cellular permeability. [7] Computational studies have shown that internal hydrogen bonding in these compounds may facilitate passive membrane permeability.…”
mentioning
confidence: 99%